Literature DB >> 27099581

Assessing Extraintestinal Manifestations of IBD.

.   

Abstract

Year:  2015        PMID： 27099581      PMCID： PMC4836570     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Authors:  Stephan R Vavricka; Lionel Brun; Pierluigi Ballabeni; Valérie Pittet; Bettina Mareike Prinz Vavricka; Jonas Zeitz; Gerhard Rogler; Alain M Schoepfer
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

2.  Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

Authors:  Adam V Weizman; Brian Huang; Stephan Targan; Marla Dubinsky; Phillip Fleshner; Manreet Kaur; Andrew Ippoliti; Deepa Panikkath; Eric Vasiliauskas; David Shih; Dermot P B McGovern; Gil Y Melmed
Journal:  J Cutan Med Surg       Date:  2014-10       Impact factor: 2.092

3.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

4.  Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.

Authors:  Rune Isene; Tomm Bernklev; Ole Høie; Pia Munkholm; Epameonondas Tsianos; Reinhold Stockbrügger; Selwyn Odes; Øyvind Palm; Milada Småstuen; Bjørn Moum
Journal:  Scand J Gastroenterol       Date:  2014-12-23       Impact factor: 2.423

5.  Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

Authors:  Millie D Long; Christopher F Martin; Clare A Pipkin; Hans H Herfarth; Robert S Sandler; Michael D Kappelman
Journal:  Gastroenterology       Date:  2012-05-11       Impact factor: 22.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.